- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06163027
Effect of Shotblocker on Procedure-related Pain, Satisfaction and Comfort in Patients Receiving Spinal Anesthesia
Effect of Shotblocker on Procedure-related Pain, Satisfaction and Comfort in Patients Receiving Spinal Anesthesia: Single-Blind, Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Spinal anesthesia is a type of anesthesia resulting from the injection of local anesthetic agents into the subarachnoid area and the blockade of the spinal nerve and dorsal root ganglia. It ensures that the patient is conscious during the operation, that spontaneous breathing continues, that the response to surgical stress is suppressed, that reflexes such as coughing and swallowing are preserved, that in addition to providing analgesia in the postoperative period, it provides rapid mobilization, facilitates the transition to early nutrition, is a low-cost technique, and has a short hospital stay. It is one of the most important advantages of spinal anesthesia. The rapid onset of effect and ease of application have made spinal anesthesia a widely preferred method in many interventions. However, most patients do not accept spinal anesthesia due to needle phobia.
The main reason for needle phobia, which is an important problem in anesthesia applications, is the occurrence of needle-related pain. Needle phobia and pain can also affect the quality of spinal anesthesia, making it difficult to administer and causing syncope.For this reason, methods such as EMLA cream, local anesthetic infiltration or application of EMLA cream before infiltration, local anesthesia application with a needle-free injection system, and vapocoolant spray are recommended to reduce superficial pain occurring under the skin / subcutaneous in spinal interventions. It has been reported that the application of local anesthetic infiltration before spinal anesthesia may cause pain during spinal needle insertion, sometimes not provide adequate analgesia, and may lead to the disappearance of anatomical signs. Local application of topical anesthetics such as EMLA cream is a painless method to reduce pain due to spinal needle insertion. However, it is recommended to apply it to the skin in a thick layer at least 30-90 minutes before the procedure to provide adequate analgesia. This situation causes various disadvantages regarding the use of EMLA cream to come to the fore. The requirement to apply it a certain time before the intervention limits its use in emergency cases. In elective cases, high and rapid patient circulation in the operating room makes it difficult to adjust the application time. Another disadvantage of EMLA cream is that it is costly. The use of local anesthetic infiltration with needle-free injection devices immediately before the procedure is also time-consuming and may interrupt the procedure and aseptic conditions if the lower or upper intervertebral space is needed for needle reinsertion. Therefore, a painless, effective and fast method is required. The shotblocker device is designed to reduce injection-related pain. ShotBlocker is reported to temporarily block peripheral nerve endings, preventing the perception and transmission of pain to the central nervous system, thus reducing pain. Pain, which is an undesirable experience for every patient, is defined as the fifth vital sign. Therefore, management of pain is very important regardless of whether it is acute or chronic. It is emphasized in the literature that the stress factors of anesthesia and surgery can be significantly reduced by relieving the pain that may occur due to various procedures. Additionally, patient satisfaction and comfort will increase. When the national and international literature was examined, only one study was found that used shotblockers to reduce pain due to spinal needle insertion. Therefore, the research was to be conducted to evaluate the effect of shot blockers on procedure-related pain, satisfaction and comfort in patients who will undergo spinal anesthesia.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being 18 years or older
- Does not have a disease that may cause loss of sensation or loss of sensation
- Be open to communication
- Volunteering to participate in research
Exclusion Criteria:
- Experiencing a change in consciousness,
- Patients receiving centrally or peripherally acting analgesics or sedatives
- Patients with clinical conditions requiring urgent intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Shotblocker
Shotblocker (experimental) group: Patients will undergo standard monitoring.
The shotblocker will be sterilized before the procedure.
Sterilization of the shotblocker will be controlled by the indicator on the packaging.
Necessary sterilization conditions for spinal anesthesia application will be met and the procedure will be performed from the L3 -L4 or L4 -L5 spinal range.
During the spinal anesthesia process, the protruding surface of the shot blocker will be placed in the area to be inserted, just before the spinal needle application.
The shotblocker will be kept stationary throughout the procedure and pressure will continue to be applied.
After entering for the spinal anesthesia procedure, the shot blocker will be removed.
During the spinal anesthesia procedure, VAS, patient satisfaction and comfort scale will be applied to the patient in the first 1 minute and at the 24th hour after surgery.
|
Shotblocher will be administered during spinal needle injection
|
|
Placebo Comparator: Placebo
Placebo group: Patients will undergo standard monitoring (electrocardiogram, noninvasive blood pressure, peripheral oxygen saturation).
The shotblocker will be sterilized before the procedure.
Sterilization of the shotblocker will be controlled by the indicator on the packaging.
Necessary sterilization conditions for spinal anesthesia application will be met and the procedure will be performed from the L3 -L4 or L4 -L5 spinal range.
During the spinal anesthesia procedure, the reverse side of the shotblocker (without protrusions) will be placed on the skin surface and gently pressed with the fingertips.
The shotblocker will be kept stationary throughout the procedure and pressure will continue to be applied.
After entering for the spinal anesthesia procedure, the shot blocker will be removed.
During the spinal anesthesia procedure, VAS, patient satisfaction and comfort scale will be applied to the patient in the first 1 minute and at the 24th hour after surgery.
|
The back side of the shotblocher will be applied during spinal needle injection
|
|
No Intervention: Control
Routine treatment and care will be applied to the control group and no intervention will be made.
During the spinal anesthesia procedure, VAS, patient satisfaction and comfort scale will be applied to the patient in the first 1 minute and at the 24th hour after surgery.
The data obtained will be recorded in the patient diagnosis form.
All interventions will be performed by the same anesthesiologist.
The data will be filled in by a healthcare professional who is blinded to the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual analog scale
Time Frame: up to 24 hours
|
The visual analog scale will be used to assess the patient's pain intensity.
It is a self-reported scale in the form of a 10- cm ruler indicating no pain at one end and unbearable pain at the other.
Accordingly, the patient is told to evaluate his/ her pain between 0 and 10, with 0 indicating "no pain" and 10 indicating "unbearable pain
|
up to 24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort Scale
Time Frame: up to 24 hours
|
Comfort scale is a measuring tool that can be used horizontally and is 10 cm long.
It starts with "most comfortable situation" and ends with "most uncomfortable situation".
Patients are asked to rate their comfort level on a scale of 1 to 10.
|
up to 24 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Patient Satisfaction Scale
Time Frame: up to 24 hours
|
The visual patient satisfaction scale consists of a 100 mm horizontal line without numbers on it.
At one end of the line, "I am not satisfied at all"; At the other end, there is the phrase "I am very satisfied".
With this scale, the patient is asked to determine his/her level of satisfaction with the care given and to mark the point on the line corresponding to his/her condition.
|
up to 24 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- tulay22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
noiVita SrlsUniversity of Eastern PiedmontCompletedCervical Pain | Pain Management | Lumbar Pain | Muscular | Chronic Pain (Back / Neck)Italy
-
Chinese University of Hong KongNot yet recruitingPain, Acute | Chronic Post Operative Pain | Pain, ChronicHong Kong
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
-
Kyowa Kirin Co., Ltd.Completed
Clinical Trials on Shotblocker
-
Dokuz Eylul UniversityCompletedPain, Acute | ComfortTurkey
-
Kirsehir Ahi Evran UniversitesiKayseri City HospitalNot yet recruitingAnxiety | Acute PainTurkey (Türkiye)
-
Istanbul Medeniyet UniversityCompletedPain | Anxiety | Injection Pain Prevention | ShotblockerTurkey
-
Yuzuncu Yıl UniversityCompleted
-
Nigde Omer Halisdemir UniversitySelcuk UniversityCompleted
-
Ataturk UniversityCompleted
-
Bornova No. 25 Mevlana Family Health CenterAtaturk Training and Research HospitalCompletedPain | Satisfaction, PatientTurkey
-
Necmettin Erbakan UniversityNot yet recruitingPain | Satisfaction
-
Istanbul Medeniyet UniversityCompleted